Aneurysmal subarachnoid hemorrhage (SAH) is a hemorrhagic stroke subtype with a poor recovery profile. Cerebral vasospasm (CV), a narrowing of the cerebral vasculature, significantly contributes to the poor recovery profile. Variation in the endothelial nitric oxide (NO) synthase (eNOS) gene has been implicated in CV and outcome after SAH. The purpose of this project was to explore the potential association between three eNOS tagging single nucleotide polymorphisms (SNPs) and recovery from SAH. We included 195 participants with a diagnosis of SAH and DNA and 6-month outcome data available but without preexisting neurologic disease/deficit. Genotyping was performed using an ABI Prism 7000 Sequence Detection System and TaqMan assays. CV was verified by cerebral angiogram independently read by a neurosurgeon on 118 participants. Modified Rankin Scores (MRS) and Glasgow Outcome Scale (GOS) scores were collected 6 months posthemorrhage. Data were analyzed using descriptive statistics, analysis of variance (ANOVA) and chi-square analysis as appropriate. The sample was primarily female (n = 147; 75.4%) and White (n = 178; 91.3%) with a mean age of 54.6 years. Of the participants with CV data, 56 (47.5%) developed CV within 14 days of SAH. None of the SNPs individually were associated with CV presence; however, a combination of the three variant SNPs was significantly associated with CV (p = .017). Only one SNP (rs1799983, variant allele) was associated with worse 6-month GOS scores (p < .001) and MRS (p < .001). These data indicate that the eNOS gene plays a role in the response to SAH, which may be explained by an influence on CV.
Adams, H.P. Jr., Kassell, N.F., Torner, J.C., & Haley, E.C. Jr. (1987). Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: Influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology, 37, 1586-1591.
2.
Afshar, J.K., Pluta, R.M., Boock, R.J., Thompson, B.G., & Oldfield, E.H. (1995). Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. Journal of Neurosurgery, 83, 118-122.
3.
Al-Yamany, M., & Wallace, M.C. (1999). Management of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Intensive Care Medicine , 25, 1463-1466.
4.
Allen, G.S., Ahn, H.S., Preziosi, T.J., Battye, R., Boone, S.C., Boone, S.C., et al. (1983). Cerebral arterial spasm- a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New England Journal of Medicine, 308, 619-624.
5.
Arai, T., Takeyama, N., & Tanaka, T. (1999). Glutathione monoethyl ester and inhibition of the oxyhemoglobin-induced increase in cytosolic calcium in cultured smooth-muscle cells. Journal of Neurosurgery, 90, 527-532.
6.
Berra, L.V., Carcereri De Prati, A., Suzuki, H., & Pasqualin, A. (2007). The role of constitutive and inducible nitric oxide synthase in the human brain after subarachnoid hemorrhage. Journal of Neurosurgical Sciences, 51, 1-9.
7.
Broderick, J.P., Brott, T.G., Duldner, J.E., Tomsick, T., & Leach, A. (1994). Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke, 25, 1342-1347.
8.
Claassen, J., Bernardini, G.L., Kreiter, K., Bates, J., Du, Y.E., Copeland, D., et al. (2001). Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited. Stroke, 32, 2012-2020.
9.
Conway, J.E., & Tamargo, R.J. (2001). Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke, 32, 2338-2343.
10.
Dehdashti, A.R., Mermillod, B., Rufenacht, D.A., Reverdin, A., & de Tribolet, N. (2004). Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovascular Disease, 17, 53-60.
11.
Dietrich, H.H., & Dacey, R.G. Jr. (2000). Molecular keys to the problems of cerebral vasospasm. Neurosurgery, 46(3), 517-530.
12.
Dorsch, N.W. (2002). Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Current Opinion in Critical Care, 8, 128-133.
13.
Dumont, A.S., Dumont, R.J., Chow, M.M., Lin, C.L., Calisaneller, T., Ley, K.F., et al. (2003). Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery, 53, 123-133; discussion 133-125.
14.
Erbs, S., Mobius-Winkler, S., Linke, A., Adams, V., Doll, N., Gielen, S., et al. (2006). Both T-786C and G894T polymorphism of endothelial nitric oxide synthase affect in-vitro endothelium-dependent relaxation of internal mammary artery rings from patients with coronary artery disease. European Journal of Cardiovascular Prevention & Rehabilitation , 13, 826-831.
15.
Fisher, C.M., Kistler, J.P., & Davis, J.M. (1980). Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery, 6, 1-9.
16.
Fujii, S., & Fujitsu, K. (1988). Experimental vasospasm in cultured arterial smooth-muscle cells. Part 1: Contractile and ultrastructural changes caused by oxyhemoglobin . Journal of Neurosurgery, 69, 92-97.
17.
Gerard, E., Frontera, J.A., & Wright, C.B. (2007). Vasospasm and cerebral infarction following isolated intraventricular hemorrhage. Neurocritical Care, 7, 257-259.
18.
Haley, E.C. Jr., Kassell, N.F., Alves, W.M., Weir, B.K., & Hansen, C.A. (1995). Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Journal of Neurosurgery, 82, 786-790.
19.
Haley, E.C. Jr., Kassell, N.F., Apperson-Hansen, C., Maile, M.H., & Alves, W.M. (1997). A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. Journal of Neurosurgery , 86, 467-474.
20.
Haley, E.C. Jr., Kassell, N.F., & Torner, J.C. (1992). The International Cooperative Study on the Timing of Aneurysm Surgery. The North American experience. Stroke , 23, 205-214.
21.
Hingorani, A.D. (2001). Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis , 154, 521-527.
22.
Hino, A., Tokuyama, Y., Weir, B., Takeda, J., Yano, H., Bell, G.I., et al. (1996). Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery, 39, 562-567; discussion 567-568.
23.
Hop, J.W., Rinkel, G.J., Algra, A., & van Gijn, J. (1997). Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke, 28, 660-664.
24.
Hunt, W.E. (1983). Clinical assessment of SAH. Journal of Neurosurgery, 59, 550-551.
25.
Ingall, T., Asplund, K., Mahonen, M., & Bonita, R. (2000). A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke, 31, 1054-1061.
26.
Iuliano, B.A., Pluta, R.M., Jung, C., & Oldfield, E.H. (2004). Endothelial dysfunction in a primate model of cerebral vasospasm. Journal of Neurosurgery , 100, 287-294.
27.
Jennett, B., & Bond, M. (1975). Assessment of outcome after severe brain damage . Lancet, 1, 480-484.
28.
Jung, C.S., Iuliano, B.A., Harvey-White, J., Espey, M.G., Oldfield, E.H., & Pluta, R.M. (2004). Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of Neurosurgery, 101, 836-842.
29.
Kajita, Y., Suzuki, Y., Oyama, H., Tanazawa, T., Takayasu, M., Shibuya, M., et al. (1994). Combined effect of l-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs . Journal of Neurosurgery, 80, 476-483.
30.
Kassell, N.F., Sasaki, T., Colohan, A.R., & Nazar, G. (1985). Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke, 16, 562-572.
31.
Kassell, N.F., Torner, J.C., Jane, J.A., Haley, E.C. Jr., & Adams, H.P. (1990). The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. Journal of Neurosurgery, 73, 37-47.
32.
Khurana, V.G., Sohni, Y.R., Mangrum, W.I., McClelland, R.L., O'Kane, D.J., Meyer, F.B., et al. (2004). Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. Journal of Cerebral Blood Flow & Metabolism, 24, 291-297.
33.
Kim, P., Schini, V.B., Sundt, T.M. Jr., & Vanhoutte, P.M. (1992). Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circulation Research , 70, 248-256.
34.
Ko, N.U., Rajendran, P., Kim, H., Rutkowski, M., Pawlikowska, L., Kwok, P.Y., et al. (2008). Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke, 39, 1103-1108.
35.
Kuhlencordt, P.J., Gyurko, R., Han, F., Scherrer-Crosbie, M., Aretz, T.H., Hajjar, R., et al. (2001). Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation, 104, 448-454.
36.
Lanzino, G., & Kassell, N.F. (1999). Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. Journal of Neurosurgy, 90, 1018-1024.
37.
Lasner, T.M., Weil, R.J., Riina, H.A., King, J.T. Jr., Zager, E.L., Raps, E.C., et al. (1997). Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgy, 87, 381-384.
38.
Lee, J.Y., Lee, M.S., Whang, K., Lee, J.M., Kim, S.H., & Lee, S.S. (2006). Accuracy of transcranial Doppler sonography for predicting cerebral infarction in aneurysmal subarachnoid hemorrhage. Journal of Clinical Ultrasound, 34, 380-384.
39.
Macdonald, R.L., & Weir, B.K. (1991). A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke, 22, 971-982.
40.
Macdonald, R.L., Weir, B.K., Marton, L.S., Zhang, Z.D., Sajdak, M., Johns, L.M., et al. (2001). Role of adenosine 5'-triphosphate in vasospasm after subarachnoid hemorrhage: Human investigations. Neurosurgery , 48, 854-862; discussion 862-853.
41.
Macdonald, R.L., Weir, B.K., Runzer, T.D., Grace, M.G., Findlay, J.M., Saito, K., et al. (1991). Etiology of cerebral vasospasm in primates . Journal of Neurosurgery, 75, 415-424.
42.
Mascia, L., Fedorko, L., terBrugge, K., Filippini, C., Pizzio, M., Ranieri, V.M., et al. (2003). The accuracy of transcranial Doppler to detect vasospasm in patients with aneurysmal subarachnoid hemorrhage. Intensive Care Medicine, 29, 1088-1094.
43.
Miller, S.A., Dykes, D.D., & Polesky, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
44.
Nakayama, M., Yasue, H., Yoshimura, M., Shimasaki, Y., Kugiyama, K., Ogawa, H., et al. (1999). T-786->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation, 99, 2864-2870.
45.
Ohman, J., Servo, A., & Heiskanen, O. (1991). Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. Journal of Neurosurgery, 74, 8-13.
46.
Olafsson, E., Hauser, W.A., & Gudmundsson, G. (1997). A population-based study of prognosis of ruptured cerebral aneurysm: Mortality and recurrence of subarachnoid hemorrhage. Neurology, 48, 1191-1195.
47.
Pluta, R.M. (2006). Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurological Research, 28, 730-737.
48.
Pluta, R.M., & Oldfield, E.H. (2007). Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. Reviews on Recent Clinical Trials, 2, 59-67.
49.
Pluta, R.M., Oldfield, E.H., & Boock, R.J. (1997). Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. Journal of Neurosurgery, 87, 746-751.
50.
Qureshi, A.I., Sung, G.Y., Razumovsky, A.Y., Lane, K., Straw, R.N., & Ulatowski, J.A. (2000). Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage . Crit Care Med, 28, 984-990.
51.
Qureshi, A.I., Suri, M.F., Yahia, A.M., Suarez, J.I., Guterman, L.R., Hopkins, L.N., et al. (2001). Risk factors for subarachnoid hemorrhage . Neurosurgery, 49, 607-612; discussion 612-603.
52.
Sawada, M., Hashimoto, N., Tsukahara, T., Nishi, S., Kaku, Y., & Yoshimura, S. (1997). Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm . Acta Neurochirurgica, 139, 706-711.
53.
Sayama, C.M., Liu, J.K., & Couldwell, W.T. (2006). Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage . Neurosurgical Focus, 21, E12.
54.
Song, J., Yoon, Y., Park, K.U., Park, J., Hong, Y.J., Hong, S.H., et al. (2003). Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations, and enzyme activity in cultured human endothelial cells. Clinical Chemistry, 49(6 Pt. 1), 847-852.
55.
Song, M.K., Kim, M.K., Kim, T.S., Joo, S.P., Park, M.S., Kim, B.C., et al. (2006). Endothelial nitric oxide gene T-786C polymorphism and subarachnoid hemorrhage in Korean population. Journal of Korean Medical Science, 21, 922-926.
56.
Sulter, G., Steen, C., De Keyser, J., Sulter, G., Steen, C., & De Keyser, J. (1999). Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke, 30, 1538-1541.
57.
Thomas, J.E. (1997). Molecular biological considerations in cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurosurgical Focus, 3, e3.
58.
Thomas, J.E., & Rosenwasser, R.H. (1999). Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: Initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery, 44, 48-57; discussion 57-48.
59.
Thomas, J.E., Rosenwasser, R.H., Armonda, R.A., Harrop, J., Mitchell, W., & Galaria, I. (1999). Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke, 30, 1409-1416.
60.
Tierney, T.S., Clatterbuck, R.E., Lawson, C., Thai, Q.A., Rhines, L.D., & Tamargo, R.J. (2001). Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer. Neurosurgery, 49, 945-951; discussion 951-943.
61.
Torbey, M.T., Hauser, T.K., Bhardwaj, A., Williams, M.A., Ulatowski, J.A., Mirski, M.A., et al. (2001). Effect of age on cerebral blood flow velocity and incidence of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke, 32, 2005-2011.
62.
Treggiari-Venzi, M.M., Suter, P.M., & Romand, J.A. (2001). Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery, 48, 249-261; discussion 261-242.
63.
van Swieten, J.C., Koudstaal, P.J., Visser, M.C., Schouten, H.J., & van Gijn, J. (1988). Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 19, 604-607.
64.
Wang, X.L., Sim, A.S., Badenhop, R.F., McCredie, R.M., Wilcken, D.E., Wang, X.L., et al. (1996). A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Medicine, 2, 41-45.
Weir, B.K., Kongable, G.L., Kassell, N.F., Schultz, J.R., Truskowski, L.L., & Sigrest, A. (1998). Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: A report of the Cooperative Aneurysm Study . Journal of Neurosurgery, 89, 405-411.
67.
Wilson, J.T., Hareendran, A., Hendry, A., Potter, J., Bone, I., Muir, K.W., et al. (2005). Reliability of the modified Rankin Scale across multiple raters: Benefits of a structured interview. Stroke, 36, 777-781.
